Serge Przedborski

Active 1989–2025

166
Papers
50,383
Citations
121
h-index
160
i10-index

Citations

Citations per year for Serge Przedborski1951: 3 citations1988: 1 citations1989: 1 citations1990: 4 citations1991: 1 citations1992: 5 citations1993: 10 citations1994: 22 citations1995: 34 citations1996: 45 citations1997: 72 citations1998: 105 citations1999: 145 citations2000: 163 citations2001: 285 citations2002: 297 citations2003: 571 citations2004: 691 citations2005: 618 citations2006: 644 citations2007: 683 citations2008: 731 citations2009: 746 citations2010: 772 citations2011: 819 citations2012: 753 citations2013: 747 citations2014: 693 citations2015: 618 citations2016: 605 citations2017: 634 citations2018: 593 citations2019: 1,569 citations2020: 1,600 citations2021: 1,555 citations2022: 1,176 citations2023: 843 citations2024: 1,165 citations2025: 525 citations2026: 17 citations1952–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,985 citing papers, 28.2% of this breakdownChina: 2,165 citing papers, 10.2% of this breakdownUnited Kingdom: 1,233 citing papers, 5.8% of this breakdownGermany: 1,073 citing papers, 5.1% of this breakdownItaly: 1,065 citing papers, 5% of this breakdownCanada: 723 citing papers, 3.4% of this breakdownFrance: 671 citing papers, 3.2% of this breakdownSpain: 647 citing papers, 3.1% of this breakdownJapan: 616 citing papers, 2.9% of this breakdownIndia: 613 citing papers, 2.9% of this breakdownSouth Korea: 579 citing papers, 2.7% of this breakdownAustralia: 531 citing papers, 2.5% of this breakdown
0%28.2%Other 25%

Fields

  • Medicine55.1%
  • Biochemistry, Genetics and Molecular Biology21.7%
  • Neuroscience16.5%
  • Immunology and Microbiology1.2%
  • Health Professions0.9%
  • Engineering0.8%
  • Other3.8%

Topics

  • Parkinson's Disease Mechanisms and Treatments12.6%
  • Neuroinflammation and Neurodegeneration Mechanisms4.6%
  • Alzheimer's disease research and treatments3.8%
  • Autophagy in Disease and Therapy3.7%
  • Mitochondrial Function and Pathology3.5%
  • Neurological disorders and treatments3.2%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Parkinson's Disease

    Authors: , - Neuron 2003 cited by 5,449

  2. Protocol for the MPTP mouse model of Parkinson's disease

    Authors: , - Nature Protocols 2007 cited by 1,105

  3. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 1,606

  4. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl - Movement Disorders 2017 cited by 845

  5. α-Synuclein Is Localized to Mitochondria-Associated ER Membranes

    Authors: , , , , , , , , - Journal of Neuroscience 2013 cited by 505

  6. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

    Authors: , , , , , , , , , , , - The Lancet Neurology 2015 cited by 509

  7. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

    Authors: , , , , , , - Nature Neuroscience 2007 cited by 1,219

  8. Parkinson’s disease: animal models and dopaminergic cell vulnerability

    Authors: , - Frontiers in Neuroanatomy 2014 cited by 464

  9. The two-century journey of Parkinson disease research

    Authors: - Nature reviews. Neuroscience 2017 cited by 346

  10. Mitochondria: The Next (Neurode)Generation

    Authors: , - Neuron 2011 cited by 574

  11. Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2008 cited by 625

  12. Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS

    Authors: , , , , , , , , , , , , , , , , - Neuron 2014 cited by 404

  13. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

    Authors: , , , , , , , , , , , , , , , , , - Neurotoxicity Research 2009 cited by 257

  14. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

    Authors: , , , - Journal of Clinical Investigation 2019 cited by 170

  15. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis

    Authors: , , - Trends in Neurosciences 2021 cited by 125

  16. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 628

  17. Freezing of gait in PD

    Authors: , , , , , , , - Neurology 2001 cited by 554

  18. Classic and New Animal Models of Parkinson's Disease

    Authors: , , , - Journal of Biomedicine and Biotechnology 2012 cited by 489

  19. D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2003 cited by 412

  20. Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Q. Trojanowski, Virginia M.‐Y. Lee, Karen Marder, D. James Surmeier, Zbigniew K. Wszołek, Serge Przedborski, Dimitri Krainc, Ted M. Dawson, Ole Isacson - Science Translational Medicine 2012 cited by 506

  21. Neuroinflammation in glaucoma: A new opportunity

    Authors: , , , , , , , , , , - Experimental Eye Research 2017 cited by 251

  22. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 659

  23. Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons

    Authors: , , , , , , , , , , - PLoS ONE 2008 cited by 361

  24. Pathogenesis of Parkinson's disease

    Authors: , , - Movement Disorders 2012 cited by 331